Machine Intelligence in Clinical Neuroscience (MICN) Laboratory, Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.
Pituitary. 2021 Aug;24(4):644-656. doi: 10.1007/s11102-021-01147-2. Epub 2021 May 4.
Residual tumor tissue after pituitary adenoma surgery, is linked with additional morbidity and mortality. Intraoperative magnetic resonance imaging (ioMRI) could improve resection. We aim to assess the improvement in gross total resection (GTR), extent of resection (EOR), and residual tumor volume (RV) achieved using ioMRI.
A systematic review was carried out on PubMed/MEDLINE to identify any studies reporting intra- and postoperative (1) GTR, (2) EOR, or (3) RV in patients who underwent resection of pituitary adenomas with ioMRI. Random effects meta-analysis of the rate of improvement after ioMRI for these three surgical outcomes was intended.
Among 34 included studies (2130 patients), the proportion of patients with conversion to GTR (∆GTR) after ioMRI was 0.19 (95% CI 0.15-0.23). Mean ∆EOR was + 9.07% after ioMRI. Mean ∆RV was 0.784 cm. For endoscopically treated patients, ∆GTR was 0.17 (95% CI 0.09-0.25), while microscopic ∆GTR was 0.19 (95% CI 0.15-0.23). Low-field ioMRI studies demonstrated a ∆GTR of 0.19 (95% CI 0.11-0.28), while high-field and ultra-high-field ioMRI demonstrated a ∆GTR of 0.19 (95% CI 0.15-0.24) and 0.20 (95% CI 0.13-0.28), respectively.
Our meta-analysis demonstrates that around one fifth of patients undergoing pituitary adenoma resection convert from non-GTR to GTR after the use of ioMRI. EOR and RV can also be improved to a certain extent using ioMRI. Endoscopic versus microscopic technique or field strength does not appear to alter the impact of ioMRI. Statistical heterogeneity was high, indicating that the improvement in surgical results due to ioMRI varies considerably by center.
垂体腺瘤手术后残留的肿瘤组织与额外的发病率和死亡率有关。术中磁共振成像(ioMRI)可以提高切除率。我们旨在评估使用 ioMRI 实现的大体全切除(GTR)、切除程度(EOR)和残留肿瘤体积(RV)的改善。
对 PubMed/MEDLINE 进行系统评价,以确定报告术中及术后(1)GTR、(2)EOR 或(3)接受 ioMRI 切除垂体腺瘤患者的残留肿瘤体积(RV)的任何研究。旨在对这三种手术结果的 ioMRI 后改善率进行随机效应荟萃分析。
在 34 项纳入的研究(2130 例患者)中,ioMRI 后转化为 GTR 的患者比例为 0.19(95%置信区间 0.15-0.23)。ioMRI 后平均 EOR 增加了 9.07%。平均 RV 为 0.784 cm。对于接受内镜治疗的患者,GTR 增加了 0.17(95%置信区间 0.09-0.25),而显微镜下 GTR 增加了 0.19(95%置信区间 0.15-0.23)。低场 ioMRI 研究显示 GTR 为 0.19(95%置信区间 0.11-0.28),而高场和超高场 ioMRI 分别显示 GTR 为 0.19(95%置信区间 0.15-0.24)和 0.20(95%置信区间 0.13-0.28)。
我们的荟萃分析表明,大约五分之一的接受垂体腺瘤切除术的患者在使用 ioMRI 后从非 GTR 转为 GTR。EOR 和 RV 也可以在一定程度上得到改善。使用 ioMRI 时,内镜与显微镜技术或场强似乎都不会改变其影响。统计异质性很高,表明由于 ioMRI,手术结果的改善在各个中心差异很大。